Preferential MRNA Expression of Prostromelysin Relative to Procollagenase and in Situ Localization in Human Articular Cartilage

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1992 Apr 1

PMID 1313449

Citations 15

Authors

Q Nguyen

J S Mort

P J Roughley

Affiliations

Soon will be listed here.

Abstract

An imbalance between extracellular proteinases and their inhibitors is thought to underlie cartilage degradation. In cultures of adult cartilage, prostromelysin mRNA levels were much higher than those for procollagenase and this differential was increased in cultures stimulated with IL-1 beta. Analysis of mRNA prepared from freshly isolated chondrocytes showed abundant amounts of prostromelysin mRNA in normal adult cartilage but low levels in the neonate. Not all adult cartilage may possess such high levels of prostromelysin mRNA, as the message levels in the cartilage remaining on late-stage osteoarthritic joints were lower than those in normal adult cartilage. Relative to prostromelysin mRNA, little procollagenase and TIMP mRNA were found in the adult cartilage. In situ hybridization revealed that metalloproteinase mRNAs were localized in chondrocytes of the superficial zone in adult cartilage. However, upon IL-1 beta treatment, chondrocytes in all cartilage zones were observed to express prostromelysin mRNA. Relative to the neonate, the normal adult cartilage appears to have a high degradative potential, if one accepts that steady-state mRNA levels reflect prostromelysin production. As the adult cartilage is not apparently undergoing rapid turnover, it would appear that control of prostromelysin activation may be the major regulatory step in stromelysin-induced cartilage degradation.

Citing Articles

Articular cartilage changes in maturing athletes: new targets for joint rejuvenation.

Luria A, Chu C Sports Health. 2014; 6(1):18-30.

PMID: 24427438 PMC: 3874229. DOI: 10.1177/1941738113514369.

Effects of Payena dasyphylla (Miq.) on hyaluronidase enzyme activity and metalloproteinases protein expressions in interleukin-1β stimulated human chondrocytes cells.

Citalingam K, Zareen S, Shaari K, Ahmad S BMC Complement Altern Med. 2013; 13:213.

PMID: 23971790 PMC: 3848702. DOI: 10.1186/1472-6882-13-213.

Interleukin-7 levels in synovial fluid increase with age and MMP-1 levels decrease with progression of osteoarthritis.

Rubenhagen R, Schuttrumpf J, Sturmer K, Frosch K Acta Orthop. 2011; 83(1):59-64.

PMID: 22206448 PMC: 3278659. DOI: 10.3109/17453674.2011.645195.

Rose hip and its constituent galactolipids confer cartilage protection by modulating cytokine, and chemokine expression.

Schwager J, Hoeller U, Wolfram S, Richard N BMC Complement Altern Med. 2011; 11:105.

PMID: 22051322 PMC: 3231956. DOI: 10.1186/1472-6882-11-105.

The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism.

Sztrolovics R, White R, Roughley P, Mort J Biochem J. 2002; 362(Pt 2):465-72.

PMID: 11853556 PMC: 1222408. DOI: 10.1042/0264-6021:3620465.

References

Woolley D, Crossley M, Evanson J . Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum. 1977; 20(6):1231-9. DOI: 10.1002/art.1780200612. View

Okada Y, Konomi H, Yada T, Kimata K, Nagase H . Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett. 1989; 244(2):473-6. DOI: 10.1016/0014-5793(89)80586-1. View

Tso J, Sun X, Kao T, Reece K, Wu R . Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 1985; 13(7):2485-502. PMC: 341170. DOI: 10.1093/nar/13.7.2485. View

Chin J, Murphy G, Werb Z . Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem. 1985; 260(22):12367-76. View

Schmid T, Mayne R, Jeffrey J, Linsenmayer T . Type X collagen contains two cleavage sites for a vertebrate collagenase. J Biol Chem. 1986; 261(9):4184-9. View

Carmichael D, Sommer A, Thompson R, Anderson D, Smith C, Welgus H . Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A. 1986; 83(8):2407-11. PMC: 323306. DOI: 10.1073/pnas.83.8.2407. View

Treadwell B, Neidel J, Pavia M, Towle C, Trice M, Mankin H . Purification and characterization of collagenase activator protein synthesized by articular cartilage. Arch Biochem Biophys. 1986; 251(2):715-23. DOI: 10.1016/0003-9861(86)90381-4. View

Murphy G, Hembry R, Reynolds J . Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Coll Relat Res. 1986; 6(4):351-63. DOI: 10.1016/s0174-173x(86)80005-x. View

Whitham S, Murphy G, Angel P, Rahmsdorf H, Smith B, Lyons A . Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J. 1986; 240(3):913-6. PMC: 1147507. DOI: 10.1042/bj2400913. View

10.

Stephenson M, Goldring M, Birkhead J, Krane S, Rahmsdorf H, Angel P . Stimulation of procollagenase synthesis parallels increases in cellular procollagenase mRNA in human articular chondrocytes exposed to recombinant interleukin 1 beta or phorbol ester. Biochem Biophys Res Commun. 1987; 144(2):583-90. DOI: 10.1016/s0006-291x(87)80006-2. View

11.

Goldring M, Birkhead J, Sandell L, Kimura T, Krane S . Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest. 1988; 82(6):2026-37. PMC: 442785. DOI: 10.1172/JCI113823. View

12.

Saus J, Quinones S, Otani Y, Nagase H, Harris Jr E, Kurkinen M . The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem. 1988; 263(14):6742-5. View

13.

Azzo W, Woessner Jr J . Purification and characterization of an acid metalloproteinase from human articular cartilage. J Biol Chem. 1986; 261(12):5434-41. View

14.

Campbell I, Roughley P, Mort J . The action of human articular-cartilage metalloproteinase on proteoglycan and link protein. Similarities between products of degradation in situ and in vitro. Biochem J. 1986; 237(1):117-22. PMC: 1146955. DOI: 10.1042/bj2370117. View

15.

Nahir A . Aerobic glycolysis: a study of human articular cartilage. Cell Biochem Funct. 1987; 5(2):109-12. DOI: 10.1002/cbf.290050205. View

16.

Tyler J . Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J. 1985; 227(3):869-78. PMC: 1144916. DOI: 10.1042/bj2270869. View

17.

Murphy G, McGuire M, Russell R, Reynolds J . Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture. Clin Sci (Lond). 1981; 61(6):711-6. DOI: 10.1042/cs0610711. View

18.

Cawston T, Galloway W, Mercer E, Murphy G, Reynolds J . Purification of rabbit bone inhibitor of collagenase. Biochem J. 1981; 195(1):159-65. PMC: 1162866. DOI: 10.1042/bj1950159. View

19.

Pelletier J, Martel-Pelletier J, Howell D, Ghandur-Mnaymneh L, Enis J, Woessner Jr J . Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum. 1983; 26(1):63-8. DOI: 10.1002/art.1780260110. View

20.

Handley C, Lowther D . Extracellular matrix metabolism by chondrocytes. III. Modulation of proteoglycan synthesis by extracellular levels of proteoglycan in cartilage cells in culture. Biochim Biophys Acta. 1977; 500(1):132-9. DOI: 10.1016/0304-4165(77)90053-8. View